2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Prostatic Neoplasms
2
Polycystic Ovary Syndrome
2
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Stomatitis
1
Sarcopenia
1
Precancerous Conditions
1
Papillomavirus Infections
1
Pain
1
Leukemia
1
Infections
1
Healthy
1
Fatty Liver
1
Colorectal Neoplasms
1
Interventions
Colposcopy
18
Imiquimod
14
Conization
12
Papillomavirus Vaccines
9
Vaccines
7
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
7
Cryotherapy
7
Biopsy
6
Acetic Acid
6
human papillomavirus vaccine, L1 type 16, 18
5
Vaginal Smears
5
Papanicolaou Test
5
Human Papillomavirus DNA Tests
5
Blood Specimen Collection
5
Watchful Waiting
4
GX-188 vaccine
4
Surveys and Questionnaires
3
Cisplatin
3
VGX-3100
2
Transurethral Resection of Prostate
2
Topotecan
2
Spectrometry, Fluorescence
2
Restraint, Physical
2
Proflavine
2
Polymerase Chain Reaction
2
Paclitaxel
2
Mass Screening
2
Indomethacin
2
Immunohistochemistry
2
Human Papillomavirus Recombinant Vaccine nonavalent
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Cervical Dysplasia
×
Olive Oil
×
Clear all
NCT02346227
2018-10-12
KINVAV
Universiteit Antwerpen
Phase 3
Completed
327 enrolled